mike@facecoach.com
HCP Only
Introducing Mike Clague Aesthetic Nurse, Bachelor of Science EN.
Mike Clague is a cosmetic nurse and co-owner of Facelove, a medical aesthetics clinic in St Kilda, Melbourne. He has worked in medical aesthetics for 23 years and has performed more than 50,000 treatments. Facelove offers practitioner-led consultations about facial ageing; whether any treatment is appropriate is determined at that consultation.
Beginning his career in medical aesthetics with Allergan, the makers of the world’s leading anti-wrinkle injection, Mike enjoyed learning techniques from some of the best injectors globally over his 6 years with this prestigious company.
Yearly training was an important part of his work at Allergan, and for 2 years Mike managed the entire training process in Australia and New Zealand, as the National Clinical Manager. He has trained over 1000 doctors and nurses in the art of injecting muscle relaxants and dermal fillers across Australia, New Zealand, Thailand, India, Malaysia and the Philippines.
Mike has worked as a consultant to Allergan Pharmaceuticals, Galderma Pharmaceuticals (global leaders in dermal fillers), Croma/Hugel and FillMed France. Mike is currently a Clinical Trainer for Galderma, Croma, FillMed and other pharmaceutical companies in Australia and New Zealand.
Majoring in Anatomy in his Science degree, Mike performed many dissections on cadavers. His detailed knowledge of anatomy enables him to produce safe and reliable outcomes. Mike is passionate about natural, undetectable results for all his clients.
Mike is registered with AHPRA and the Nursing and Midwifery Board as a nurse No. NMW0001618803
Contact Mike90’s Supermodels, to me, personify beauty. Natural beauty. Nothing artificial, nothing overstated.
Nobody wants their friends or their partner asking ‘What have you done to your face?'
I want a natural, undetectable result for each of my patients, enhancing their natural features and beauty.
Mike's research concerns the prevention and emergency management of complications in aesthetic practice, and it is what he is best known for internationally.
In 2016, with Professor Greg Goodman AM, he co-authored the paper that first proposed the supraorbital and supratrochlear injection route for emergency hyaluronidase administration in filler-associated vision loss, as an alternative to the retrobulbar approach then in standard use. The 2020 Australian and New Zealand consensus statement of which Mike is a named author adopted that route and cited the 2016 paper as its authority for it. The route is now the recommended first-line in-clinic pathway in the RANZCO Guideline for Filler Blindness (2024), which directs clinicians to administer hyaluronidase at the supraorbital foramen or supratrochlear notch, reserving retrobulbar injection for those specifically trained in it. Mike is second author of the 2026 UK consensus guidelines on the same subject, and has presented on this work internationally.
Vision loss following injection is a rare but serious complication, and no treatment reliably restores vision. That is precisely why Mike's teaching and clinical practice place their primary emphasis on prevention, anatomical technique and immediate recognition.
Mike is also first author of a novel protocol for hypertrophic scar reduction, developed over more than a decade of practice and published as a case series in Plastic and Aesthetic Nursing (2024), which received the ISPAN Journal Award.
Vision loss following injection is a rare but serious complication, and no treatment reliably restores vision. That is precisely why Mike's teaching and clinical practice place their primary emphasis on prevention, anatomical technique and immediate recognition.
Mike began his career in medical aesthetics at Allergan, where over six years he was trained by internationally recognised injectors including Dr Mauricio de Maio, Dr Michael Kane, Dr Ava Shamban, Dr Mary Lupo, Dr Alastair Carruthers, Dr Jean Carruthers, Dr Hervé Raspaldo, Dr Steven Liew and Professor Greg Goodman AM
He has since trained more than 6,000 doctors and nurses across Australia, New Zealand, the United States, Thailand, India, Malaysia and the Philippines, and has consulted for Allergan, Galderma, Croma Pharma (Austria), ALMA Lasers, Lutronic, FILLMED, HUGEL Aesthetics and Xytide.
Mike is an Adjunct Lecturer (Practice) at Monash University, teaching alongside Professor Greg Goodman AM, dermatologist. His course covers patient suitability assessment, clinical governance, ethics, regulatory compliance and screening for body dysmorphic disorder. He holds a BSc (Anatomy) from Monash and serves on the board of the Cosmetic Nurses Association. He has 12 peer-reviewed publications.
Sansome S, Clague M, Convery C, et al. Consensus Guidelines for the Management of Tissue Filler–Induced Vision Loss in the United Kingdom. Aesthetic Surgery Journal. 2026. DOI 10.1093/asj/sjag002
Goodman GJ, Magnusson MR, Callan P, … Clague M, et al. A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management. Aesthetic Surgery Journal. 2020;40(9):1009–1021. DOI 10.1093/asj/sjz312
Goodman GJ, Clague MD. A rethink on hyaluronidase injection, intraarterial injection, and blindness. Dermatologic Surgery. 2016;42(4):547–549. DOI 10.1097/dss.0000000000000670
Clague MD, Goodman G, Taing C, et al. Hyperdiluted Botulinum Toxin and Intense Pulsed Light Treatment: A Case Series to Illustrate a Novel Protocol for Hypertrophic Scar Reduction. Plastic and Aesthetic Nursing. 2024;44(2):116–123. DOI 10.1097/PSN.0000000000000551
Shamban A, Clague MD, von Grote E, Nogueira A. A Novel and More Aesthetic Injection Pattern for Malar Cheek Volume Restoration. Aesthetic Plastic Surgery. 2018. DOI 10.1007/s00266-017-0981-1
Papers Mike has co-authored have received the AlliedPro Featured Article award from Aesthetic Surgery Journal (Best Papers of the Year, 2024) and ASJ Open Forum (2025), both voted by the journals' editorial boards.
Mike is known for natural, undetectable results. His approach prioritises patient safety, realistic expectations and reliable outcomes, and every patient begins with a thorough suitability assessment. All treatments carry risks, which are discussed at consultation. Mike has performed over 50,000 injectable treatments.
Mike consults at Facelove, G04, 173 Barkly Street, St Kilda VIC 3182. Bookings: facelove.com.au
Mike is registered with AHPRA and the Nursing and Midwifery Board as a nurse No. NMW0001618803
Over 19 years industry experience, 12 years clinical experience in the medical aesthetics market. Mike believes beauty is not in the eye of the beholder, it is in the eye of your clinician.
Mike enjoys creating artistic results for all his clients. He has a training company Facecoach and has taught across Australia and New Zealand.
